Related Experiment Videos
A comparative study of azithromycin and pseudoephedrine hydrochloride for otitis media with effusion in children
M A Safak1, R Kiliç, I Haberal
1Ministry of Health, Ankara Training and Research Hospital, Turkey. masafak@doctor.com
Insights
Azithromycin, an antibiotic, proved more effective than pseudoephedrine hydrochloride (PHCl) for treating otitis media with effusion (OME) in children. A weekly azithromycin regimen showed promising results with good patient compliance.
Area of Science:
- Pediatric Otolaryngology
- Pharmacology and Therapeutics
Background:
- Otitis media with effusion (OME) is a common pediatric condition requiring effective treatment.
- Current treatment options for OME include antibiotics and decongestants, with varying efficacy.
- Optimizing treatment regimens for OME is crucial for improving outcomes and patient compliance.
Purpose of the Study:
- To compare the efficacy of azithromycin and pseudoephedrine hydrochloride (PHCl) for treating persistent OME in children.
- To evaluate different azithromycin dosing regimens for OME management.
- To assess treatment outcomes using objective measures like tympanometry and pneumatic otoscopy.
Main Methods:
- A double-blind, randomized clinical study involving 90 children aged 2-13 years with persistent OME.
- Three treatment groups: Group 1 (azithromycin daily for 3 days, then weekly), Group 2 (azithromycin daily for 1 week, then weekly), Group 3 (PHCl 3 times daily).
- Treatment duration up to 12 weeks, with assessments at baseline and Weeks 4, 8, and 12 using pneumatic otoscopy and tympanometry.
Main Results:
- Azithromycin treatment groups demonstrated superior outcomes compared to the pseudoephedrine hydrochloride (PHCl) group.
- No statistically significant difference was observed between the two azithromycin treatment protocols.
- The once-weekly azithromycin regimen facilitated better patient compliance and effective treatment.
Conclusions:
- Azithromycin is an effective treatment for otitis media with effusion (OME) in children.
- A once-weekly azithromycin regimen offers a practical and effective approach to OME management.
- Azithromycin therapy, especially the weekly schedule, improves treatment compliance and achieves favorable outcomes with minimal intervention.
Abstract:
We compared the outcomes of two different regimens--azithromycin and pseudoephedrine hydrochloride (PHCl)--for the treatment of otitis media with effusion (OME) in children. In a double-blind randomized clinical study, a total of 90 children aged between 2 and 13 years with persistent OME were randomly assigned to one of 3 treatment groups. The first group received azithromycin at a dose of 10 mg/kg once daily for 3 days and this regimen was repeated weekly for up to 12 weeks according to the results of tympanometry and pneumatic otoscopy. The second group received azithromycin at a dose of 10 mg/kg once daily for 3 days for the first week, and this regimen was repeated for 1 day a week for the following 11 weeks. The third group received PHCl, 4 mg/kg, 3 times daily for up to 12 weeks. Each patient underwent pneumatic otoscopic and tympanometric investigations at baseline and at Weeks 4, 8 and 12. The outcomes in the azithromycin-treated groups were superior to that in the decongestant group. However, the difference between the outcomes in the azithromycin groups according to the treatment protocol was not statistically significant. Azithromycin therapy, particularly a once-weekly regimen, helps patients to comply with treatment and also helps us to achieve good results with minimal therapy.